Bone morphogenetic protein (BMP) signaling pathway plays important roles in urinary tract development although the detailed regulation of its activity in this process remains unclear. Here we report that follistatin-like 1 (Fstl1), encoding a secreted extracellular glycoprotein, is expressed in developing ureter and antagonizes BMP signaling activity. Mouse embryos carrying disrupted Fstl1 gene displayed prominent hydroureter arising from proximal segment and ureterovesical junction defects. These defects were associated with significant reduction in ureteric epithelial cell proliferation at E15.5 and E16.5 as well as absence of subepithelial ureteral mesenchymal cells in the urinary tract at E16.5 and E18.5. At the molecular level, increased BMP signaling was found in Fstl1 deficient ureters, indicated by elevated pSmad1/5/8 activity. In vitro study also indicated that Fstl1 can directly bind to ALK6 which is specifically expressed in ureteric epithelial cells in developing ureter. Furthermore, Sonic hedgehog (SHH) signaling, which is crucial for differentiation of ureteral subepithelial cell proliferation, was also impaired in Fstl1 -/-ureter. Altogether, our data suggest that Fstl1 is essential in maintaining normal ureter development by antagonizing BMP signaling.
Introduction
Congenital malformations of the kidney and urinary tract are the primary causes of renal failure in children and young adults [1] and frequently affect human infants. Many of these hereditary diseases display hydroureter and/or hydronephrosis with dilatation of the ureter and/or the renal pelvis, caused by failure to conduct urine from the renal pelvis to the bladder [2, 3] . The underlying causes of these congenital malformations are still largely unknown.
Murine urinary tract development is a model that is broadly used to understand the underlying mechanism of human urinary tract malformations. On gestational day 10.5 (E10.5), ureteric bud, an epithelial outgrowth from Wolffian duct (WD), appears at the level of the future hind limbs. Then the ureteric bud invades a condensation of the intermediate mesoderm, called metanephric mesenchyme, and is induced by metanephric mesenchyme to branch from E11.5 onwards to develop to the renal collecting duct system [4, 5] . The primary stalk of the ureteric bud that connects the developing kidney first to the Wolffian duct and later to the bladder, develops to become the ureter. The most posterior Wolffian duct segment is called the common nephric duct (CND), which connects ureteric bud to urogenital sinus, the later bladder [5, 6] . In later developmental stages, the CND undergoes apoptosis to let the ureter join urogenital sinus directly [7] . The ureter budding site along the Wolffian duct as well as the appropriate CND absorption process are important to the final position of ureterovesical junction and distal ureter maturation.
During ureter development, the epithelial cells differentiate into the urothelium, while a layer of smooth muscle cells are differentiated from the condensed mesenchymal cells around the ureteric epithelium, and mediate peristalsis, conducting urine from the renal pelvis to bladder. In later stage, another kind of mesenchymal cells is differentiated between smooth muscle layer and epithelium in ureter, called subepithelial ureteral mesenchymal cells. Recent report revealed that Shh from ureteric epithelium is required for differentiation of subepithelial ureteral mesenchymal cells. Deletion of Shh in urothelium causes absent of subepithelial ureteral mesenchymal cells. The mutant mice display congenital renal hypoplasia, hydronephrosis and hydroureter phenotype at birth [8] .
BMP signaling pathway is essential for many development processes. During ureter development, Bmp4 and Bmp5 are expressed in ureteral mesenchymal cells, while Bmp7 is expressed in ureteric epithelium [9] . Gene targeting approaches have uncovered some of their important roles during ureter development. Bmp7 deficient mice display a dysplastic kidney and hydroureter phenotype [10, 11] . Mice heterozygous for a null mutation of Bmp4 display abnormalities that mimic human congenital anomalies of the kidney and urinary tract (CAKUT), suggesting that Bmp4 has important functions in the early development of urinary tract by inhibiting ectopic budding from WD or the ureter stalk [12] . At later stage, Bmp4 is reported to have multiple biological functions in urinary system development. For instance Bmp4 can act on the metanephric mesenchyme, prevents cell death and promotes expansion and migration of mesenchymal cells [13] . Fstl1 encodes a secreted extracellular glycoprotein that belongs to the BM/SPARC/osteonectin family, which contains an extracellular calcium-binding (EC) domain and a follistatin (FS)-like domain [14, 15] . In zebrafish, morpholino knockdown of zFstl2 (the mouse Fstl1 homolog) results in a ventralized body axis [16] . Recently, Fstl1 is indicated to act as a BMP4 signaling antagonist in lung development [17] . Nevertheless, how Fstl1 affects BMP signaling or the function of Fstl1 during ureter development remains unclear.
Clues about Fstl1 function in the developing urinary system is suggested by its dynamic expression in the nephric duct and the nascent nephron epithelia of the developing kidney [18] . In this study, we report that Fstl1 knockout mice (Fstl1 -/-) display a prominent hydroureter beginning at E16.0. Our histological and biochemical results suggest that Fstl1 has important roles in regulating ureteric epithelial cell proliferation, subepithelial ureteral mesenchymal cells differentiation and distal ureter maturation, mainly via regulating BMP and SHH signaling pathways.
Materials and Methods

Ethics Statement
This study was approved by the Institutional Animal Care and Use Committee of Model Animal Research Center, Nanjing University, in strict accordance with the Guide for the Care and Use of Laboratory Animals, China. The relevant approved animal protocol (MARC-AP#: XG28) is entitled ''Fstl1 antagonizes BMP signaling by regulating epithelial-mesenchymal interaction during ureter development''.
Mouse Strains
Fstl1 floxed mice (Fstl1 flox/+ ) were generated by inserting two loxP sites into intron 1 and intron 2 respectively, followed by a neomycin cassette and a third loxP site in same orientation [19] . Heterozygous Fstl1 knockout mice (Fstl1 +/-) were generated by crossing Fstl1 flox/+ mice with EIIa-Cre mice (B6.FVB-Tg(EIIacre)C5379Lmgd/J, 003724), in which Cre recombinase expression occurs prior to implantation in the uterine wall [20] . Intercross of Fstl1 +/-mice produced null mutant mice (Fstl1 -/-) with exon 2 deletion. Ptch-lacZ +/-mice (STOCK Ptch1 tm1Mps /J, 003081) were obtained from The Jackson Laboratory (Bar Harbor, ME). Fstl1 knockout mice (Fstl1
) as well as Fstl1
+/-;Ptch-lacZ +/-mice were kept at 129;B6 mixed background. All mice were maintained in an AAALAC accredited SPF facility in Model Animal Research Center of Nanjing University.
Histology and Immunohistology
For histological staining, urinary system was fixed in 4% paraformaldehyde, paraffin-embedded, sectioned (6mm), and stained with hematoxylin-eosin. Immunohistochemistry was performed on paraffin sections following a standard protocol with antibodies listed below [21] .
For X-gal staining of urinary systems, the whole urinary tract was fixed for 30min in fixative buffer (0.05 M NaPO 4 buffer, PH 7.3, 1.8% formaldehyde, 0.02% NP-40, 2 mM MgCl 2 , 0.01% deoxycholate) on ice. After fixation, the urinary systems were washed 5 min in rinse buffer (0.05 M NaPO 4 buffer, PH 7.3, 0.02% NP-40, 2 mM MgCl 2 ) for three times and stained by immersion in X-gal staining solution (0.05 M NaPO 4 buffer, PH 7.3, 2 mM MgCl 2 , 5 mM potassium ferrocyanide, 5 mM potassium ferricyanide, 0.1% X-gal) overnight at 37uC in the dark. The X-gal-stained urinary systems were rinsed with PBS, and post-fixed with 4% paraformaldehyde in PBS at 4uC. Then the samples were paraffin embedded and sectioned (10 mm). The sections were counterstained with nuclear fast red.
Antibodies
Antibodies and reagents used are as follows: goat anti-Fstl1 (R&D system, AF1738), goat anti-Smad1 (R&D system, AF2039), rabbit anti-phospho-Smad1/5/8 (Cell Signaling Technology, 9511), rabbit anti-Pax2 (Zymed, 71-6000), DAPI (Sigma-Aldrich, D9542), rabbit anti-pan-Cytokeratin (Santa Cruz Biotechnology, SC-15367), mouse anti-a-SMA (Neomarkers, MS-113-P1), goat anti-SM22 a (Abcam, ab10135), mouse anti-smMHC (Abcam, ab53219), mouse anti-phospho-AKT (Ser 473 ) (Cell Signaling Technology, 4051), rabbit anti-AKT (Cell Signaling Technology, 9272), mouse anti-b-actin (Sigma, A5441), mouse anti-GAPDH (Santa Cruz Biotechnology, SC-32233), mouse anti-c-Myc (Santa Cruz Biotechnology, SC-40), mouse anti-HA (Sigma-Aldrich, H3663), FITC-conjugated mouse (Sigma-Aldrich, F5262) and Cy5-conjugated rabbit (Biomeda Corp., SJ29004) secondary antibodies and DAB (Maixin, KIT-9710), Goat anti-mouse IgG (Fc) (Pierce, 31439), Rabbit anti-Goat IgG (Sigma-Aldrich, A5420), and Goat anti-Rabbit IgG (Sigma-Aldrich, A9169).
Dye Injection
To visualize the urinary tract lumen, Bromophenol blue was injected into the pelvic region of the kidneys using a three dimensional manipulator (MN-153, NARISHIGE).
Analysis of Peristalsis
E18.5 kidneys and associated ureters were dissected from wildtype and Fstl1 -/-embryos and were incubated in an in vitro culture chamber attached to an Olympus X71 inverted microscope. Ureter movements were observed and captured by digital camera of the microscope apparatus.
Proliferation and Apoptosis Analysis
To determine proliferative activity of the developing ureter, Timed-mated pregnant females were intraperitoneal injected with 10ml/g body weight BrdU (5mg/ml) (Sigma-Aldrich). E15.5 urinary systems were harvested 1 hour after injection, and E16.5 urinary systems were collected 2 hours after injection. For E15.5 embryos, a total of over 20 ureter sections from three embryos of each genotype were collected for quantification. For E16.5 embryos, a total of 20 ureter sections from the distal segment of ureter of each genotype were collected for quantification. Proliferative activity was examined after treatment with Fstl1 in culture: Wild-type E15.0 urinary system (kidney, ureter and bladder) was dissected and positioned on top of a culture plate insert (0.4 mm pore size, Millipore Corporation, Bedford, MA01730, USA) within an individual well of a 24-well tissue culture plate and cultured in mock or Fstl1-containing conditioned media for 16 hours, with 10 mM BrdU added during the last 4 hours of treatment [22] . A total of 7 sections from 3 pairs of cultured ureters were used for quantification. The BrdU-labeling index was defined as the number of BrdU-positive nuclei relative to total number of nuclei, which were counterstained with hematoxylin.
Apoptotic cells were detected using TUNEL assay that performed on 6mm paraffin sections using DeadEnd TM Fluoro-metric TUNEL System (Promega, G3250). For both E15.5 and E16.5 embryos, a total of 6 ureter sections from two embryos of each genotype were analyzed. For E12.5 embryos, a total of 6 sections containing CND region from two embryos of each genotype were analyzed.
In Situ Hybridization
In situ hybridization was performed as previously described [23] . A 619 bp 3' UTR fragment of Fstl1 cDNA was subcloned into the pBluescript II KS (-) (Stratagene) plasmid, which was used to generate an in situ hybridization probe (PCR primers are listed in Table S1 ). Pax3 probe was kindly provided by Dr. Yingzi Yang from NIH as a gift. Pax2 probe was provided by Dr. Yeguang Cheng (Tsinghua University, Beijing, China) as a gift. 3 embryos of each stage were used for Fstl1 expression examination. 4 embryos of each genotype were used for whole mount in situ hybridization using Pax2 and Pax3 probes.
Quantitative Real-Time PCR
The ureters were dissected and separated from the rest of the kidney. Two pairs of ureter were pooled into one sample. Over 4 groups of each genotype were used for real-time PCR for each gene. Total RNA from E16.5 ureter samples was isolated using the Qiagen RNeasy Mini kit (Qiagen). First strand cDNA was synthesized using AMV reverse transcriptase (Takara). Primers targeting specific transcripts were designed for real-time RT-PCR (SYBR). b-actin was used as internal control in each reaction. Quantitative real-time PCR was performed using an ABI PRISM 7700 (ABI) with conditions recommended by the manufacturer. Each reaction was performed triplicate. The quantity of each experimental sample is first determined using a standard curve based on their Ct values and then expressed relative to the internal control. The primers used to amplify each gene are listed in Table  S1 .
Cell Culture and Transfection
HEK-293 (CRL-1573
TM , ATCC) cells were routinely cultured in DMEM supplemented with 10% FBS. Fstl1 coding sequence was subcloned into pcDNA3.1 (Invitrogen) vectors to express Fstl1 with (pcDNA3.1-Myc-Fstl1) or without Myc-tag (pcDNA3.1-Fstl1). HA tagged ALK3, ALK5 and ALK6 plasmids were provided by Dr. Yeguang Cheng (Tsinghua University, Beijing, China) as gifts.
To prepare the conditioned media, pcDNA3.1-Fstl1 or pcDNA3.1 vector (Mock) were transfected into cells using Lipofectamine 2000 (Invitrogen) following the manufacturer's instructions. 24 hours after transfection, supernatant medium was collected as conditioned media for following treatment. The cells subject to conditioned media treatment were plated at 3610 5 per well in 12 well plate, and starved for 4 hours before medium changed. Cells were treated with the conditioned media in addition of BMP4 (20 ng/ml) (PeproTech, Rocky Hill, NJ) for 30 min.
Immunoprecipitation and Western Blot
For immunoprecipitation assay, HEK293 and COS7 cells were co-transfected with pcDNA3.1-Myc-Fstl1 and Bmp receptors expression plasmids HA-ALK3, ALK6 or ALK5. After transfection, the cells were cultured for 48 hours. Whole cell lysate was incubated with anti-c-Myc antibody, and rotated at 4uC for 6 hours. Then Protein A/G Agarose beads (Biyuntian Bio) were added and incubated overnight at 4uC with rotation.
Protein extracts (50mg/lane) were separated on discontinuous 10% SDS-PAGE gel followed by transfer to PVDF membrane (Amersham Biosciences), 100V for 1 hr. The transferred membrane was blocked in 5% skim milk in TTBS (0.1% Tween-20 in TBS) buffer for 1hr at RT, then immunoblotted with primary antibody overnight at 4uC. After four washes with TTBS for 10 min each, the membrane was incubated with peroxidasecoupled secondary antibody for 1 hr at RT. After three washes in TBS for 10 min each, the immuno-reactive bands were visualized with a chemiluminescent substrate for peroxidase (Super Signal West Pico substrate, Pierce). For ureter samples, ureters were dissected and separated from the rest of the kidney. 10 pairs of ureters from each genotype were pooled together as one sample. The experiments from both E15.5 and E16.5 ureters were duplicated. The results on E18.5 kidney samples were confirmed with more than 4 litters of embryos.
Statistics
All results were presented as mean 6 SEM. All statistical analyses were done using GraphPad Prism5 software. Two-tailed Student's t tests were used for comparisons between two groups. *, p,0.05; **, p,0.01; ***, p,0.001. p,0.05 was considered significant.
Results
Fstl1 is Expressed in Developing Ureter
We examined Fstl1 expression in the developing ureter by immunohistochemistry (IHC) at E11.5 ( Figure. Since Fstl1 is a secreted glycoprotein, Fstl1 mRNA expression was also examined by in situ hybridization. Fstl1 mRNA was mainly produced in ureteral mesenchymal cells at E13.5 (Figure. 
Fstl1 -/-Embryos Developed Congenital Hydroureter and Hydronephrosis
To study the function of Fstl1 in development and pathophysiology, Fstl1 conventional knockout allele was generated by crossing heterozygous conditional knockout mice (Fstl1 flox/+ ) [19] with EIIa-Cre mice (B6.FVB-Tg (EIIa-cre) C5379Lmgd/J, 003724) [20] .
Fstl1 -/-mice died shortly after birth due to severe lung developmental defects [17, 24] . We found Fstl1 mutant embryos also displayed profound hydroureter and hydronephrosis at birth. In order to define the onset and progression of urinary tract malformations in Fstl1
-/-embryos, we analyzed urinary systems of wild-type and Fstl1 -/-embryos from E15.0 to E17.5 ( Figure Kidney was also examined. Since Fstl1 was highly expressed in collecting duct in kidney at E17.5 [18] , Pax2 expression was examined as a colleting duct marker. From E15.5 to E17.5, Pax2 expression level in the collecting duct of mutant kidneys was normal ( Figure. S2 ). However, from these histological results, we found that Fstl1 mutant kidney was reduced in size and displayed the dilatation of the pelvis and atrophy of papilla at E17.5, suggesting Fstl1 -/-kidneys exhibited hydronephrosis at this stage ( Figure. S2E, F) . Obvious enlargement of renal pelvis was not observed in Fstl1 embryo at E15.5 ( Figure. S2A, B ) and E16.5 ( Figure. S2C, D) , therefore we speculate that hydronephrosis was possibly a secondary consequence of hydroureter.
Physical obstruction is a potential cause of ureter dilation during urinary system development. To determine whether there was complete physical obstruction along the urinary tract in Fstl1 mutant embryo, we injected dye directly into the pelvic region of E18.5 Fstl1 -/-kidneys. The purple dye could flow through the (Figure. 2D ). This result indicates that the hydroureter phenotype wasn't caused by a complete obstruction.
Defects of Distal Ureter and Ureterovesical Orifice in Fstl1 -/-Embryos
Ureterovesical junction defects were observed in many hydroureter mouse models [25, 26] as well as human patients with CAKUT [1] . Previous report also revealed that Bmp4 heterozygote mutant embryos display ureterovesical junction defects with high penetrance [12] . Fstl1 is suggested to be a BMP signaling antagonist [17] . Therefore, we examined the ureterovesical orifice as well as the distal ureter of Fstl1 -/-embryos. We found that the very distal segment of Fstl1 -/-ureters was extremely narrow (Figure. +/-embryo [12] . These results suggested that Fstl1 deficiency caused developmental defects in the distal part of ureter and ureterovesical junction.
During the development of urinary tract, ureteric bud first binds to the Wolffian duct, migrates to cloaca, and finally joins bladder. The abnormality of ureterovesical orifice could be caused by ectopic initial ureteric budding site or by defects of subsequent processes, such as the absorption of common nephric duct (CND) [7, 12, 25, 27, 28] . Therefore, we examined ureterovesical junction in earlier developmental stages. At E11.0, we investigated whether aberrant ureteral budding occurred. Wild-type (n = 4) and Fstl1 -/-(n = 4) embryos were subjected to in situ hybridization using Pax2 and Pax3 antisense probes. Pax2 is expressed in the epithelial ureteric bud in the urinary system [29] , while Pax3 is expressed in many tissues, including the somites [30] . Then we analyzed the embryos after in situ hybridization of both probes, and we found that both in wild-type (Figure. At E12.5, when the ureter still binds the WD, the CND is actively absorbed into the cloaca by apoptosis [7] . We thus examined the length and apoptotic level of the CND in Fstl1 
Inactivation of Fstl1 Results in Defective Ureteric Epithelial Cell Proliferation and Differentiation
The hydroureter is often associated with cell proliferation and/ or apoptosis defects during ureter development [8, 13, 31, 32, 33, 34] . Beside the dilation of ureter at proximal part, we also found the distal ureter of Fstl1 mutant embryo is significantly narrower than that of wild-type embryo. Therefore, we examined proliferation and apoptosis in Fstl1 -/-embryonic ureters. Very few cells in wildtype and Fstl1 -/-ureters underwent apoptosis at E15.5 as determined by the TUNEL assay. There was no significant difference in ureteric epithelium and ureteral mesenchyme between wild-type and mutant embryos ( Figure. S4A, B) . Similar results were obtained in E16.5 ureters (Figure. S4C, D) .
We examined proliferation of ureteric epithelium and ureteral mesenchyme by BrdU incorporation in E15.5 wild-type and Fstl1 -/-ureters ( Figure. 4A, B, E) . There was no change in the rate of mesenchymal cell proliferation ( Figure. 4E) . On the contrary, proliferation of Fstl1 -/-ureteric epithelium was significantly reduced at E15.5 ( Figure. 4E) . At E16.5, the proximal segment of Fstl1 -/-ureter was already dramatically dilated. Therefore, we analyzed the proliferation rates of distal segment of ureter, which was narrower in To determine whether urothelium differentiation was affected in Fstl1 deficient mice, we examined the expression of Upk3a, a urothelium differentiation marker [35, 36] , in E15.5 and E16.5 ureters. Expression of Upk3a was down-regulated in Fstl1 -/-ureters compared to wild-type at E15.5 and E16.5 as determined by realtime PCR (Figure. S5 ), suggesting that urothelium differentiation is also impaired in the Fstl1 -/-ureter.
Subepithelial Ureteral Mesenchymal Cells were Absent in Fstl1 -/-Ureter
Previous studies have suggested that the hydroureter may result from defects in ureteral mesenchymal cell differentiation [8, 31] . So we examined the expression of mesenchymal cell markers in the Fstl1 -/-ureter. At E15.5, the expression level of smooth muscle differentiation markers a-SMA ( Figure. To further examine the contractile function of ureter smooth muscle, E18.5 (Movie S1, S2) kidneys and associated ureters were isolated and cultured. Ureter movements were observed. We found that even in late stages that the morphology of mutant ureters dramatically changed, contraction of the smooth muscle seemed to be normal in Fstl1 -/-embryos (Movie S2) compared with wild-type embryos (Movie S1).
A layer of a-SMA-negative mesenchymal cells was differentiated between the ureteric epithelium and the multilayer a-SMApositive mesenchymal cells in later developmental stages [8] . These cells, referred to as the subepithelial ureteral mesenchymal cells, are also absent in Shh and Dlgh1 mutants displaying hydroureter phenotype [8, 37] . We traced differentiation of these cells in both wild-type and Fstl1 -/-ureters from E15.5 to E18.5, by double staining of epithelial cell marker pan-cytokeratin and smooth muscle cell marker a-SMA. At E15.5 and E16.0, we could not detect that type of cells negative for both of these markers in either wild-type (Figure. Figure. 5F, L). We didn't detect any cell that is negative for both markers in dilated Fstl1 -/-ureters. SHH signaling pathway is crucial for subepithelial ureteral mesenchymal cells differentiation and ureter development [8] . Therefore, we analyzed Shh expression in the developing ureter at E16.5. We found that Shh was down-regulated in the Fstl1 -/-ureter as determined by real-time PCR (Figure. 5M) . Ptch is the receptor of Shh as well as one of the downstream targets of SHH signal [38] . Using Ptch-lacZ +/-mice, in which lacZ is knocked-in to the Ptch locus, subepithelial ureteral mesenchymal cells can be exclusively labeled by X-gal staining at E18.5 [8, 38] . Therefore, we used this mouse strain to examine SHH signaling in Fstl1 mutants. X-gal staining at E16.5 and E18.5 was performed. At E16.5, Ptch-lacZ was expressed in mesenchymal cells in wild-type ureters ( Figure. 5N ). X-gal staining signal was weaker in the Fstl1 -/-;Ptch-lacZ +/-ureters ( Figure. 5O ) than in the Fstl1 +/+ ;PtchlacZ +/-ureters ( Figure. 5N ). In E18.5 embryos, X-gal staining signal in Fstl1 +/+ ;Ptch-lacZ +/-ureters was strong in subepithelial ureteral mesenchymal cells ( Figure. 
Fstl1 Deficiency Led to up-regulation of BMP Signaling in Developing Ureter and Kidney
Previous reports have suggested a correlation between Fstl1 and BMP signaling [16, 17, 39] , and that BMP signaling is important for urinary system development [2] . We examined the effect of Fstl1 deficiency on BMP signaling in the urinary system. Smad1/ 5/8 phosphorylation levels in the ureter and kidney were analyzed by western blot (Figure. 6A, first, second, and third panels). There was an increase of Smad1/5/8 activities in Fstl1 -/-ureter at E15.5 ( Figure. 6A, left panels), and E16.5 ( Figure. 6A, second panels) compared to wild-type ureter. The increased Smad1/5/8 phosphorylation level was also detected in Fstl1 -/-kidneys Figure. S8E, F) .
TGF-b signaling was determined by western blots of phosphorylated Smad2. Smad2 activity was not affected by the Fstl1 deficiency in E18.5 kidney or E15.5 ureter (Figure. S9) .
Previous reports indicated that Fstl1 plays important roles in the cardiovascular system via AKT signal pathway [40, 41] , so we also examined the effect of Fstl1 deficiency on AKT signal. Phosphorylation level of AKT at Ser 473 decreased in Fstl1 -/-kidneys at E18.5 ( Figure. 6A, third panels) . But the AKT activity was not affected by Fstl1 deficiency in E15.5 ( Figure. 6A, left panels) and E16.5 ( Figure. 6A, second panels) ureter.
Since we detected an increased BMP signal in Fstl1 -/-ureter, we then examined the levels of multiple BMP/TGF-b signal ligands and receptors, including Bmp2, Bmp4, Bmp5, Bmp7, Tgf-b1, Alk3, Alk6, Alk5, BmprII, ActrIIa, and ActrIIb. The expression level of these BMP/TGF-b signal ligands and receptors were not altered in Fstl1 -/-ureter at E16.5 as determined by real-time PCR (Figure. 6B ). These results are consistent with previous speculation that Fstl1 acted as a BMP antagonist [16, 17, 39] .
To further confirm the function of Fstl1 on BMP signaling, we examined the effect of Fstl1 in HEK293 cells using Fstl1-containing conditioned media. Serum-starved HEK293 cells were treated with Fstl1-containing conditioned media and 20 ng/ml recombinant BMP4. Following BMP4 stimulation, BMP signal was activated. Smad1/5/8 phosphorylation level was lower in cells treated with Fstl1-containing conditioned media compared to the control conditioned media ( Figure. 6A, right penals), suggesting that Fstl1 can antagonize BMP4-induced Smad1/5/8 activation in HEK293 cells. By performing a similar in vitro assay in HEK293 cells, we found that Fstl1 also had mild inhibitory effects on BMP2 (10 ng/ml) stimulation (Figure. S10A, lane 3, 5) .
We then sought to identify potential ligand or receptor that physically interacts with Fstl1. Since BMP ligands and Fstl1 are both secreted proteins, we focused on identifying BMP receptors. We performed co-immunoprecipitations (co-IP) using Myc-tagged Fstl1 and HA-tagged BMP/TGF-b receptors, including ALK3, ALK5, and ALK6 in HEK293 cells. Using anti-HA antibody following IP from whole cell lysates with an anti-c-Myc antibody, we found that HA-ALK6 could be detected in IP protein from HEK293 cells (Figure. 6C ). To confirm this result, we also performed same co-IP assay in COS7 cells, and found that both HA-ALK6 and HA-ALK3 could be detected in IP protein from COS7 cells (Figure. S10B ). These in vitro results suggested that BMP type I receptors may be potential Fstl1 binding targets in vivo that mediates its antagonizing effect during ureter development.
Discussion
Ureter development is a complicated process involving organogenesis at least at two directions, the elongation of the ureter stalk and the differentiation of ureteric epithelial and mesenchymal layers. BMP and SHH signaling pathways have been reported to participate in regulation of these developmental processes. However, the precise control of these pathways remains obscure. In this study, we provided substantial evidences suggesting that Fstl1, a secreted protein, plays important roles during urinary tract development by antagonizing BMP signal ( Figure. 7) . Disruption of Fstl1 causes multiple defects in developing urinary tract, including hydroureter arising from proximal segment as well as ureterovesical junction defects. Furthermore, Fstl1 deficiency also results in down-regulated SHH signal, which in turn may affect subepithelial ureteral mesenchymal cells differentiation through mesenchymal-epithelial interaction ( Figure. 7) .
The function of FSTL1 on regulating BMP signaling may be mediated at both receptor and ligand level. For receptors, the key issue is that FSTL1 interacts with different targets depending on specific cell types. In our previous paper analyzing lung phenotype of Fstl1 gene targeting mice, the Hep3B cell line was used mostly because of the endoderm tissue origin of lung epithelium [17] . For Hep3B cell line, FSTL1 can pull down BMPRII, but not BMPR1B (ALK6). In this study, we used HEK293 cell line which is derived from human embryonic kidney cells because we focused on ureter development. We found that only ALK6 can be coprecipitated with FSTL1 in HEK293. When we used another kidney derived cell line, COS7, both ALK6 and ALK3 can be coprecipitated. Nevertheless, Alk6 is specifically expressed in the ureteric epithelial cells in the urinary tract [12] . Consistent with the previous studies, our results suggest that Alk6 may be potential Fstl1 binding target in vivo that mediates its antagonizing effect during ureter development. It will be interesting, however, to elucidate the detailed mechanism how Fstl1 functions in vivo in different tissues in the future.
In addition, structure prediction and previous work in zebrafish, Xenopus and chick indicates that Fstl1 functions as a BMP antagonist similar to follistatin [16, 39, 42] . Because FSTL1 also binds to BMP(s) [17, 43] , it is possible that the interaction between FSTL1 and other TGF-b superfamily members may also contribute to the role of FSTL1 in vivo. Therefore, Fstl1 may have a broad inhibitory effect on BMP signaling pathway by targeting both ligands and receptors.
Our results are consistent with the previous suggestion that BMP signaling regulates ureter development. Bmp4 heterozygous mutants and Bmp7 mutants caused defects in urinary tract development. Bmp7 deficiency caused renal dysplasia and hydroureter phenotype [10, 11] ,while Bmp4 heterozygous mutants exhibit multiple defects in urinary system, which is similar with human congenital anomalies of the kidney and urinary tract CAKUT [12] . Indirectly, Gata2 mutant animals resemble human congenital anomalies of the kidney and urinary tract as a result of reduction in BMP4 abundance [27, 44] . These data indicated reduced BMP signaling is deleterious for urinary tract development. On the other hand, genetic inactivation of the BMP antagonist gremlin 1 (Grem1) leads to disruption of metanephric development at the stage of ureteric bud outgrowth initiation [45] , indicating BMP antagonists play an essential role in negatively modulating the activity of BMP signals during early kidney development [45, 46] . Our data also add more evidence that precise BMP signaling regulation is important in ureter development after ureteric bud initiation.
Relatively little is known about the mesenchymal-epithelial interaction in ureter development, compared to detailed studies that have focused on the ureteric buds interaction with its surrounding metanephric mesenchymal cells during kidney induction [4, 47] . Recently, it was discovered that Fstl1 was a diffusible mesenchymal factor that determined the epithelium fate during oviduct development [48] . Coincidentally, both Fstl1 and Bmp4 are expressed in the ureteral mesenchyme [12] . Our model provides genetic evidence of the existence of signals, such as BMP, from the ureteral mesenchymal layer that affect ureteric epithelium function.
Hydroureter is often associated with cell proliferation and/or apoptosis defects during ureter development in several animal models [8, 12, 13, 31, 33] . In most of these published mouse models, decreased ureteral mesenchymal cell proliferation causes impaired smooth muscle differentiation, finally resulting in a functional obstruction due to defective smooth muscle movement. Although Fstl1 mRNA is mainly expressed in the ureteral mesenchyme, there were no significant anomalies in proliferation, apoptosis, or differentiation of Fstl1 null ureteral mesenchyme. On the contrary, the impaired ureteric epithelial proliferation was observed and considered as cause of very narrow distal segment ureters, which makes it difficult for urine to go through, and contributes to hydroureter/ hydronephrosis phenotype.
There is increasing evidence that BMP signaling modulates cell proliferation during development. For instance, overexpressing BMP4 in lung epithelium and hair follicles result in a reduction of proliferation in lung epithelium and the outer root sheath cells in transgenic mouse models [49, 50] . Studies using in vitro models suggest that exogenous BMP4 inhibits epithelial cell proliferation and ductal budding in cultured urogenital sinus tissues [51] . Genetic inactivation of Fstl1 leads to an increased BMP signaling, especially in ureteric epithelium. Consistent with BMP signaling activation, ureteric epithelial cell proliferation was reduced in Fstl1 mutant ureters at E15.5 and E16.5. However, the detail mechanism still needs more studies.
Besides impaired epithelial cell proliferation, Fstl1 -/-ureter also displays defects in subepithelial ureteral mesenchymal cell differentiation. The absence of subepithelial ureteral mesenchymal cells in the Fstl1 -/-ureter is similar with the phenotype in Shh mutant ureter. Deletion of Shh in the urothelium results in congenital obstructive phenotypes and the subepithelial ureteral mesenchymal cells is missing in this mouse model, suggesting SHH signal plays crucial role in inducing subepithelial ureteral mesenchymal cells differentiation [8] . In Dlgh1 mutant ureter, the subepithelial ureteral mesenchymal cells which are referred as Raldh2 positive ureteric stromal cells, are also absent. The authors further speculate that this population of cells might provide flexibility during the contraction and relaxation phases of peristalsis, so the missing of these cells might contribute to the hydroureter phenotype [37] . In our study, the time point that subepithelial ureteral mesenchymal cells differentiated and the time point of hydroureter phenotype in Fstl1 -/-to display are also concomitant. Consistent with previous reports suggesting that SHH signaling is crucial for subepithelial ureteral mesenchymal cells differentiation [8] , we also observed a down-regulation of SHH signaling in the Fstl1 -/-ureter. Our results indicate that Fstl1 is required to maintain or establish the subepithelial ureteral mesenchymal cells through at least in part of SHH signal. However, the origin of this cell population is still largely unknown. One possible model is this cell population is derived from the ureteral mesenchymal cells. However, more studies are needed to elucidate the origin and the function of this specific ureteral cell population. Although we observed that SHH signal is down-regulated in Fstl1 -/-ureter, the hydroureter phenotype of Fstl1 ureter is more severe than Shh conditional mutant in ureteric epithelium. Fstl1 deficiency caused a down-regulated SHH signal as well as upregulated BMP signal in urinary tract. Both signals play important regulatory roles in ureter development. The interactions between BMP and SHH signaling are important regulatory mechanisms in multiple developmental processes, including the neural tube patterning, tooth morphogenesis, hair follicle growth induction, limb bud formation, gut development, and left-right determination [52, 53, 54, 55, 56, 57, 58] . Many BMP antagonists regulate the interaction between these two signals [52, 54, 57] . During ureter development, previous reports indicate that SHH signaling could induce Bmp4 activation and promote ureteral mesenchyme proliferation [8] . Our results provide hints that BMP signal could negatively regulate SHH signal, and Fstl1 plays important roles to maintain the balance between these two signaling pathways. However, detailed studies are required to elucidate the exact way that Fstl1 regulates SHH signal. Anyway, Fstl1 mutant mice provide a good model to study the mechanisms of the interaction between SHH and BMP signaling pathways to regulate cell proliferation and differentiation during ureter development and in congenital malformations of the urinary tract.
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